|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Asociación para Evitar la Ceguera en México |
|---|---|
| Information provided by: | Asociación para Evitar la Ceguera en México |
| ClinicalTrials.gov Identifier: | NCT00802698 |
Purpose
The purpose of this study is to describe the effect of transcorneal electrical stimulation (TES) with a non conventional biphasic bipolar waveform in central retinal artery occlusion
| Condition | Intervention | Phase |
|---|---|---|
|
Central Retinal Artery Occlusion |
Device: Transcorneal electric stimulation Device: Transcorneal stimulation Device: transcorneal electric stimulation |
Phase I Phase II |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Estimated Enrollment: | 5 |
| Study Start Date: | April 2008 |
| Estimated Primary Completion Date: | April 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Group 1 |
Device: Transcorneal electric stimulation
central artery occlusion
Other Name: TES
Device: Transcorneal stimulation
new waveform
Other Name: TES
Device: transcorneal electric stimulation
Novel waveform central artery occlusion
Other Name: TES
|
Patients with acute central retinal artery occlusion (CRAO) generally present with a history of painless visual loss that occurred over several seconds. In some instances amaurosis fugax is also present. At the time of initial examination, visual acuity in 90% of patients with CRAO can vary from counting fingers to light perception. Acute CRAO is considered an emergency situation, and therapy must be started as soon as possible. There are different reports where different treatments were proved for the acute phase for example: ocular massage, anterior chamber paracentesis, intravenous mannitol, acetazolamide, hyperbaric oxygenation, microcatheter urokinase infusion, and carbogen 1,2,3. Electrophysiological occlusion of the ophthalmic artery, central retinal artery occlusion, or central retinal vein has a profound impact on the ERG. ERG can provide an objective assessment of severity if occlusion occurs, the b wave is eliminated and a reduction in the "a" wave can be observed.
In addition, a traumatic optic neuropathy, together with retinal ganglion cell death, can induce a loss of vision which progresses rapidly within several hours l. It is known that the visual prognosis following treatment of acute central retinal artery occlusion is not as good as we would like 2; the patient must go to any emergency department to be treated immediately3, in order to preserve maximal visual function. It has been prove that the retinal function recovers after an ischemic event lasting up to 97 minutes, 4 and irreparable damage may occur after 105 minutes. This is why this study intervene during the chronic phase between 4 hrs and 14 days; where demonstrable clinical improvements in the magnitude of retinal damage where seen5, 6, 7 However recently research reports have shown that, electrical stimulation can rescue injured retinal ganglion cells from death cells and can preserve visual function after an optic nerve crush. 8 There is no ideal treatment in the chronic phase of the CRAO. That is the reason why most recent papers suggest different treatment approaches in the chronic phase of this pathology. One of these treatments that were described is the application of electrical stimulation on the patient's cornea who present with CRAO. It has been reported in the literature that transcorneal, retinal 9,10 or cerebral visual cortex 11 electrical stimulation (ES) results in evoked visual sensations (phosphenes),6,9,10,12 however, this intervention requires surgical electrode implantation.
Eligibility| Ages Eligible for Study: | 50 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Miriam Jessica López-Miranda, MD | 10841400 ext 1171 | retinamex@yahoo.com |
| Contact: Miriam Jessica Lopez-Miranda, MD | 10841400 ext 1172 | jessicalop@hotmail.com |
| Mexico | |
| APEC | Recruiting |
| Mexico, Mexico, 04030 | |
| Contact: Miriam Jessica Lopez-Miranda, MD 10841400 ext 1171 retinamex@yahoo.com | |
| Sub-Investigator: Daniel Robles-Camarillo, MSc | |
| Sub-Investigator: Hugo Quiroz -Mercado, MD | |
| Sub-Investigator: Luis Niño-de-Rivera y Oyarzabal, PhD | |
| Sub-Investigator: Gerardo García-Aguirre, MD | |
| Sub-Investigator: Virgilio Morales-Cantón, MD | |
| Principal Investigator: | Miriam Jessica Lopez-Miranda, MD | APEC |
More Information
| Responsible Party: | Asociación para evitar la ceguera en méxico, APEC |
| ClinicalTrials.gov Identifier: | NCT00802698 History of Changes |
| Other Study ID Numbers: | APEC-039 |
| Study First Received: | December 3, 2008 |
| Last Updated: | December 4, 2008 |
| Health Authority: | Mexico: Ministry of Health |
|
Biphasic waveform Central retinal artery occlusion To describe the effect of Transcorneal Electrical Stimulation (TES) with a non conventional biphasic bipolar waveform in central retinal artery occlusion |
|
Retinal Artery Occlusion Arterial Occlusive Diseases Retinal Diseases |
Eye Diseases Vascular Diseases Cardiovascular Diseases |